Latest Content

New AHN research shows high-intensity resistance training is safe and essential for breast cancer survivors to gain strength and functional mobility.

New therapies are beginning to crack KRAS, offering tumor shrinkage and longer survival as researchers work to overcome resistance.

Elrexfio improved progression-free survival in multiple myeloma, helping patients live longer without disease worsening in a phase 3 trial.

Transitioning from active cancer treatment brings a new kind of uncertainty. Learn how to navigate life when the medical guardrails are removed.

Dr. David Greenberg outlines bladder cancer staging, BCG, immunotherapy, surgery, quality of life impacts and long-term follow-up care strategies.

Dr. Ramy Sedhom highlights screening and care pathways that improve outcomes and strengthen psychosocial support for patients with cancer.

Diagnosed with both AIDS and cancer, a writer finds solace in the Cape May surf and the profound gift of a friend truly engaging with his life’s work.

KRAS was long thought undruggable in cancer until scientists discovered a hidden binding pocket in mutant KRAS, leading to targeted therapies.

New immunotherapy use before and after surgery improves outcomes, making early symptom recognition and expert care more critical than ever.

Urologist Dr. Susan MacDonald breaks down the differences between soft tissue and blood cancers while highlighting common and rare disease types.

Phase 3 trial shows Datroway significantly extended overall and progression-free survival in patients with previously untreated, advanced TNBC ineligible for immunotherapy.

MD Anderson’s Dr. Wendy Woodward discusses breath-hold techniques, insurance hurdles, and proton therapy’s role in reducing radiation cardiac toxicity.

Dr. Tony Anderson speaks about fertility preservation options for men and women before cancer treatment, emphasizing early testing and timely referral.